Article
Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
Diabetes technology & therapeutics - 1 Jun 2013
Cleary Patricia A, Braffett Barbara H, Orchard Trevor, Lyons Timothy J, Maynard John, Cowie Catherine, Gubitosi-Klug Rose A, Way Jeff, Anderson Karen, Barnie Annette, Villavicencio Stephan
Abstract excerpt
BACKGROUND: The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications(EDIC) studies have established multiyear mean hemoglobin A1c (HbA1c) as predictive of microvascular complications in persons with type 1 diabetes. However, multiyear mean HbA1c is not always available in the clinical setting. Skin advanced glycation end products (AGEs) are thought to partially...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.